Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy.
Int J Pharm. 2013 Jun 25;450(1-2):21-30. doi: 10.1016/j.ijpharm.2013.04.023. Epub 2013 Apr 20.
Int J Pharm. 2013.
PMID: 23608202
Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
Liu M, Li W, Larregieu CA, Cheng M, Yan B, Chu T, Li H, Mao SJ.
Liu M, et al. Among authors: larregieu ca.
Mol Pharm. 2014 Jul 7;11(7):2305-12. doi: 10.1021/mp400759d. Epub 2014 Jun 3.
Mol Pharm. 2014.
PMID: 24830852
Item in Clipboard
Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.
Larregieu CA, Benet LZ.
Larregieu CA, et al.
Mol Pharm. 2014 Apr 7;11(4):1335-44. doi: 10.1021/mp4007858. Epub 2014 Mar 28.
Mol Pharm. 2014.
PMID: 24628254
Free PMC article.
Item in Clipboard
Improving the prediction of the brain disposition for orally administered drugs using BDDCS.
Broccatelli F, Larregieu CA, Cruciani G, Oprea TI, Benet LZ.
Broccatelli F, et al. Among authors: larregieu ca.
Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. doi: 10.1016/j.addr.2011.12.008. Epub 2011 Dec 21.
Adv Drug Deliv Rev. 2012.
PMID: 22261306
Free PMC article.
Review.
Item in Clipboard
Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.
Larregieu CA, Benet LZ.
Larregieu CA, et al.
AAPS J. 2013 Apr;15(2):483-97. doi: 10.1208/s12248-013-9456-8. Epub 2013 Jan 24.
AAPS J. 2013.
PMID: 23344793
Free PMC article.
Item in Clipboard
The FDA should eliminate the ambiguities in the current BCS biowaiver guidance and make public the drugs for which BCS biowaivers have been granted.
Benet LZ, Larregieu CA.
Benet LZ, et al. Among authors: larregieu ca.
Clin Pharmacol Ther. 2010 Sep;88(3):405-7. doi: 10.1038/clpt.2010.149. Epub 2010 Jul 28.
Clin Pharmacol Ther. 2010.
PMID: 20668447
Free PMC article.
Item in Clipboard
Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
Li J, Larregieu CA, Benet LZ.
Li J, et al. Among authors: larregieu ca.
Chin J Nat Med. 2016 Dec;14(12):888-897. doi: 10.1016/S1875-5364(17)30013-4.
Chin J Nat Med. 2016.
PMID: 28262115
Review.
Item in Clipboard
Cite
Cite